ONCOLYTICS BIOTECH INC

Analysis for Ticker: ONCY

Oncolytics Biotech Inc is a clinical stage company that says it develops an intravenous therapy called pelareorep to turn cold tumors into hot ones to fight cancer. The reality is that since its birth in 1998, this operation has functioned as a machine to move cash from the public into private hands, accumulating a deficit of 429,5$ million without ever selling a product. The math is a disaster because the company does not exist to cure patients, but to manufacture and sell its own stock to pay for a massive office and expensive bosses. Imagine a lemonade stand that never sells lemonade but survives only by selling pieces of the stand to new kids while the original owners take all the lunch money for themselves.